IGM Biosciences Inc.

IGMS

Held by 2 specialist biotech funds

Specialists adding · Low short pressure

Share on X

Fund Holdings

Redmile Group

Baker Bros. Advisors

2 quarters

Position Trend

May 15, 2025

$8.1M

2 funds

Aug 14, 2025

$7.9M

2 funds

Nov 14, 2025

$0

0 funds

Feb 17, 2026

$0

0 funds

-100% total institutional value over 4 quarters

Catalysts

No catalysts tracked.

Activist Filings

SC 13D/ABaker Bros. Advisors12.4%Mar 28, 2024

SC 13D/ABaker Bros. Advisors11.4%Dec 15, 2023

SC 13D/ABaker Bros. Advisors10.0%Jun 28, 2023

SC 13D/ABaker Bros. Advisors11.6%Apr 5, 2022

SC 13D/ABaker Bros. Advisors12.4%Jan 29, 2021

SC 13D/ABaker Bros. Advisors12.4%Jan 5, 2021

SC 13D/ABaker Bros. Advisors10.0%Dec 11, 2020

SC 13DBaker Bros. Advisors13.0%Sep 20, 2019

Position Details

Redmile GroupEXITFeb 17, 2026

Shares: 0Value: N/A

Baker Bros. AdvisorsEXITFeb 17, 2026

Shares: 0Value: N/A

+ 6more — see how much conviction went in

See the Full Story

Know which insider moves are real

See who's buying with their own money vs. routine exercises
AI explains why each move matters right now

Start 7-Day Free Trial — $29/mo

Insider Signals

No insider signals tracked.

Also Held by These Funds

FDMT2 funds ABSI2 funds IDYA2 funds KYMR2 funds NRIX2 funds STOK2 funds IMVT2 funds AKRO2 funds

Research Links

Yahoo Finance →SEC EDGAR →ClinicalTrials.gov →

Track specialist biotech funds, insider signals, and AI analysis

Start 7-Day Free Trial

Or get the free weekly brief: